Occurrence of extended-spectrum β-lactamases and plasmid-mediated AmpC β-lactamases among Korean isolates of Proteus mirabilis [6]

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 1, 2006, Pages 156-158

  Park, Yeon Joon ^a   Lee, Seungok ^b   Kim, Yang R ^a   Oh, Eun Jee ^a   Woo, Gun Jo ^c   Lee, Kyungwon ^d  

^a The Catholic University of Korea   (South Korea)

^b Seoul Medical Science Institute   (South Korea)

^c Korea Food and Drug Administration   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

ESBLs; P. mirabilis; Plasmids

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE AMPC; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; KOREA; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PROTEUS MIRABILIS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; HUMANS; KOREA; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PROTEUS INFECTIONS; PROTEUS MIRABILIS;

EID: 30344467229     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki408     Document Type: Letter

References (6)

1. Chanal C, Bonnet R, De Champs C et al. Prevalence of β-lactamases among 1,072 clinical strains of Proteus mirabilis: A 2-year survey in a French hospital. Antimicrob Agents Chemother 2000; 44: 1930-5.
2. Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical centre. J Clin Microbiol 2000; 38: 1791-6.
3. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Sixth Edition: Approved Standard M7-A6. NCCLS, Wayne, PA, USA, 2003.
4. Tzelepi E, Giakkoupi P, Sofianou D et al. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol 2000; 38: 542-6.
5. Yong D, Park R, Yum JH et al. Further modification of the Hodge test to screen AmpC β-lactamase (CMY-1)-producing strains of Escherichia coli and Klebsiella pneumoniae. J Microbiol Methods 2002; 51: 407-10.
6. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-62.